Personen

TOP 5 Publikationen:

1. Mechler K, Banaschewski T, Hohmann S, Häge A. Evidence-based pharmacological treatment options for ADHD in children and adolescents.Pharmacol Ther. 2022 230:107940. Epub 2021 Jun 23.
2. Mechler K, Mountford WK, Hoffmann GF, Ries M. Ultra-orphan diseases: a quantitative analysis of the natural history of molybdenum cofactor deficiency.Genet Med. 2015 17(12):965-70. Epub 2015 Mar 12.
3. Purper-Ouakil D, Blasco-Fontecilla H, Ros T, Acquaviva E, Banaschewski T, Baumeister S, Bousquet E, Bussalb A, Delhaye M, Delorme R, Drechsler R, Goujon A, Häge A, Kaiser A, Mayaud L, Mechler K, Menache C, Revol O, Tagwerker F, Walitza S, Werling AM, Bioulac S, Brandeis D. Personalized at-home neurofeedback compared to long-acting methylphenidate in children with ADHD: NEWROFEED, a European randomized noninferiority trial.J Child Psychol Psychiatry. 2022 63(2):187-198. Epub 2021 Jun 24.
4. Bohner A, Blasco-Fontecilla H, Ros T, Acquaviva E, Attal Y, Banaschewski T, Baumeister S, Bousquet E, Bussalb A, Delhaye M, Delorme R, Drechsler R, Goujon A, Häge A, Mayaud L, Mechler K, Menache C, Revol O, Tagwerker F, Walitza S, Werling AM, Bioulac S, Brandeis D, Purper-Ouakil D, Kaiser A. Emotional problems and dysregulation in children/youth with ADHD: predictive and moderating effects in a randomized controlled trial of methylphenidate and neurofeedback.J Child Psychol Psychiatry. 2026 Jul 28. [Epub ahead of print].
5. Ziegler M, Aggensteiner PM, Becker K, Döpfner M, Geißler J, Hohmann S, Huber R, Igel C, Janson K, Mechler K, Millenet S, Romanos M, Brandeis D, Banaschewski T, Kaiser A. Insights from 24-hour actigraphy using functional linear modeling in children with and without ADHD.Sci Rep. 2025 15(1):37161.